HUP1400520A2 - Laquinimod salts useful for the preparation of pharmaceutical compositions - Google Patents
Laquinimod salts useful for the preparation of pharmaceutical compositionsInfo
- Publication number
- HUP1400520A2 HUP1400520A2 HU1400520A HUP1400520A HUP1400520A2 HU P1400520 A2 HUP1400520 A2 HU P1400520A2 HU 1400520 A HU1400520 A HU 1400520A HU P1400520 A HUP1400520 A HU P1400520A HU P1400520 A2 HUP1400520 A2 HU P1400520A2
- Authority
- HU
- Hungary
- Prior art keywords
- laquinimod
- preparation
- pharmaceutical compositions
- salts useful
- salts
- Prior art date
Links
- GKWPCEFFIHSJOE-UHFFFAOYSA-N laquinimod Chemical class OC=1C2=C(Cl)C=CC=C2N(C)C(=O)C=1C(=O)N(CC)C1=CC=CC=C1 GKWPCEFFIHSJOE-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU1400520A HUP1400520A2 (en) | 2014-11-03 | 2014-11-03 | Laquinimod salts useful for the preparation of pharmaceutical compositions |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU1400520A HUP1400520A2 (en) | 2014-11-03 | 2014-11-03 | Laquinimod salts useful for the preparation of pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP1400520A2 true HUP1400520A2 (en) | 2016-05-30 |
Family
ID=89991635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU1400520A HUP1400520A2 (en) | 2014-11-03 | 2014-11-03 | Laquinimod salts useful for the preparation of pharmaceutical compositions |
Country Status (1)
| Country | Link |
|---|---|
| HU (1) | HUP1400520A2 (en) |
-
2014
- 2014-11-03 HU HU1400520A patent/HUP1400520A2/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201605300B (en) | Pharmaceutical compositions comprising azd9291 | |
| GB201419257D0 (en) | Pharmaceutical compositions | |
| GB201618482D0 (en) | Pharmaceutical compositions | |
| IL247062A0 (en) | Heterocyclic compounds , their preparation and compositions pharmaceutical containing them | |
| HUE047041T2 (en) | Process for the preparation of polyetheramines | |
| GB201409471D0 (en) | Pharmaceutical composition | |
| IL249553A0 (en) | Pharmaceutical compositions | |
| IL246447B (en) | Pharmaceutical preparation containing pyridylaminoacetic acid compound | |
| GB201409488D0 (en) | Pharmaceutical composition | |
| GB201409485D0 (en) | Pharmaceutical composition | |
| PL3200772T3 (en) | Pharmaceutical compositions comprising alpelisib | |
| ZA201702086B (en) | Long acting pharmaceutical compositions | |
| ZA201606075B (en) | Pharmaceutical compositions of sitagliptin | |
| PT3157506T (en) | Taste-masked oral pharmaceutical composition | |
| ZA201700843B (en) | Oral pharmaceutical composition of isotretinoin | |
| IL250817A0 (en) | Pharmaceutical compositions | |
| IL251559B (en) | Pharmaceutical composition of fused aminodihydrothiazine derivative | |
| GB201400117D0 (en) | Pharmaceutical composition | |
| PL3223799T3 (en) | A process for preparation of a drug-polymer composition | |
| SG11201608123VA (en) | Pharmaceutical composition for external use | |
| GB201409869D0 (en) | Pharmaceutical composition | |
| HUP1600415A2 (en) | Pimavanserin salts for the manufacture of pharmaceutical formulations | |
| HUP1400520A2 (en) | Laquinimod salts useful for the preparation of pharmaceutical compositions | |
| SG11201608124XA (en) | Pharmaceutical composition for external use | |
| HUP1400519A2 (en) | Crystalline form of laquinimod and sodium salt thereof useful for the preparation of pharmaceutical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC4A | Lapse of provisional application due to refusal |